Assyro AI

FDA Orange Book · active-ingredient family

Methamphetamine hydrochloride

Methamphetamine hydrochloride is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DESOXYN · NDA 005378

1

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, tablet, extended release

ProductApplicantApplicationTEApproved
DESOXYNRLD×4AJENAT PHARMSNDA 005378AAApproved Prior to Jan 1, 1982

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
METHAMPHETAMINE HYDROCHLORIDEHIKMAANDA 203846AANov 17, 2015
METHAMPHETAMINE HYDROCHLORIDEDR REDDYS LABS SAANDA 091189AAApr 21, 2010
METHAMPHETAMINE HYDROCHLORIDEABLEANDA 040529Feb 25, 2004
METHAMPEXTEVAANDA 083889Approved Prior to Jan 1, 1982
METHAMPHETAMINE HYDROCHLORIDE×2REXARANDA 084931Approved Prior to Jan 1, 1982
METHAMPHETAMINE HYDROCHLORIDETEVAANDA 086359Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Methamphetamine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.